T. Wiesner, R. Murali, I. Fried, L. Cerroni, K. Busam et al., A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression, Am J Surg Pathol, vol.36, pp.818-830, 2012.

J. W. Harbour, M. D. Onken, E. D. Roberson, S. Duan, L. Cao et al., Frequent mutation of BAP1 in metastasizing uveal melanomas, Science, vol.330, pp.1410-1413, 2010.

M. Bott, M. Brevet, B. S. Taylor, S. Shimizu, T. Ito et al., The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma, Nat Genet, vol.43, pp.668-672, 2011.

S. Peña-llopis, S. Vega-rubín-de-celis, A. Liao, N. Leng, A. Pavía-jiménez et al., BAP1 loss defines a new class of renal cell carcinoma, Nat Genet, vol.44, pp.751-759, 2012.

G. Guo, Y. Gui, S. Gao, A. Tang, X. Hu et al., Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma, Nat Genet, vol.44, pp.17-19, 2011.

T. Wiesner, A. C. Obenauf, R. Murali, I. Fried, K. G. Griewank et al., Germline mutations in BAP1 predispose to melanocytic tumors, Nat Genet, vol.43, pp.1018-1021, 2011.

J. R. Testa, M. Cheung, P. J. Below, J. E. Tan, Y. Sementino et al., Germline BAP1 mutations predispose to malignant mesothelioma, Nat Genet, vol.43, pp.1022-1025, 2011.

T. Popova, L. Hebert, V. Jacquemin, S. Gad, V. Caux-moncoutier et al.,

J. , N. A. Sastre-garau, X. Desjardins, L. Gyapay, and G. , Germline BAP1 mutations predispose to renal cell carcinomas, Am J Hum Genet, vol.92, pp.974-980, 2013.

J. C. Scheuermann, A. G. De-ayala-alonso, K. Oktaba, N. Ly-hartig, R. K. Mcginty et al., Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB, Nature, vol.465, pp.243-247, 2010.

A. Dey, D. Seshasayee, R. Noubade, D. M. French, J. Liu et al., Loss of the tumor suppressor BAP1 causes myeloid transformation, Science, vol.337, pp.1541-1546, 2012.

D. E. Jensen, M. Proctor, S. T. Marquis, H. P. Gardner, S. I. Ha et al., BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression, Oncogene, vol.16, pp.1097-1112, 1998.

H. Yu, N. Mashtalir, S. Daou, I. Hammond-martel, J. Ross et al., The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression, Mol Cell Biol, vol.30, pp.5071-5085, 2010.

S. Misaghi, S. Ottosen, A. Izrael-tomasevic, D. Arnott, M. Lamkanfi et al., Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1, Mol Cell Biol, vol.29, pp.2181-2192, 2009.

Y. J. Machida, Y. Machida, A. A. Vashisht, J. A. Wohlschlegel, and A. Dutta, The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1, J Biol Chem, vol.284, pp.34179-34188, 2009.

H. I. Baymaz, A. Fournier, S. Laget, J. Z. Jansen, P. W. Smits et al., MBD5 and MBD6 interact with the human PR-DUB complex through their methyl-CpGbinding domain, Proteomics, vol.14, pp.2179-2189, 2014.

L. M. Lafave, W. Beguelin, R. Koche, M. Teater, B. Spitzer et al., Loss of BAP1 function leads to EZH2-dependent transformation, Nat Med, vol.21, pp.1344-1349, 2015.

M. Schoumacher, L. Corre, S. Houy, A. Mulugeta, E. Stern et al., Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status, Nat Med, vol.22, pp.577-578, 2016.

P. Kapur, S. Pena-llopis, C. A. Zhrebker, L. , P. et al., Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation, Lancet Oncol, vol.14, pp.159-167, 2013.

H. B. Ruan, X. Han, M. D. Li, J. P. Singh, K. Qian et al., O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1alpha stability, Cell Metab, vol.16, pp.226-237, 2012.

K. H. Ventii, N. S. Devi, K. L. Friedrich, T. A. Chernova, M. Tighiouart et al., BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization, Cancer Res, vol.68, pp.6953-6962, 2008.

Z. M. Eletr, L. Yin, and K. D. Wilkinson, BAP1 is phosphorylated at serine 592 in S-phase following DNA damage, FEBS Lett, vol.587, pp.3906-3911, 2013.

J. J. Sacco, J. Kenyani, Z. Butt, R. Carter, H. Y. Chew et al., Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors, Oncotarget, vol.6, pp.13757-71, 2015.

A. De-reynies, M. C. Jaurand, A. Renier, G. Couchy, I. Hysi et al., Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition, Clin Cancer Res, vol.20, pp.1323-1334, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02478599

D. Trachootham, W. Lu, M. A. Ogasawara, R. D. Nilsa, and P. Huang, Redox regulation of cell survival, Antioxid Redox Signal, vol.10, pp.1343-1374, 2008.

E. Giannoni, M. Parri, and P. Chiarugi, EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy, Antioxid Redox Signal, vol.16, pp.1248-1263, 2012.

G. E. Gibson, A. Starkov, J. P. Blass, R. R. Ratan, and M. F. Beal, Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases, Biochim Biophys Acta, vol.1802, pp.122-134, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00562927

M. Yilmaz and G. Christofori, Mechanisms of motility in metastasizing cells, Mol Cancer Res, vol.8, pp.629-642, 2010.

C. Luchini, N. Veronese, S. Yachida, L. Cheng, A. Nottegar et al., Different prognostic roles of tumor suppressor gene BAP1 in cancer: A systematic review with meta-analysis, Genes Chromosomes Cancer, vol.55, pp.741-749, 2016.

A. Toullec, D. Gerald, G. Despouy, B. Bourachot, M. Cardon et al., Oxidative stress promotes myofibroblast differentiation and tumour spreading, EMBO Mol Med, vol.2, pp.211-230, 2010.

K. A. Matatall, O. A. Agapova, M. D. Onken, L. A. Worley, A. M. Bowcock et al., BAP1 deficiency causes loss of www.impactjournals.com/oncotarget melanocytic cell identity in uveal melanoma, BMC Cancer, vol.13, p.371, 2013.

D. Valenti, L. De-bari, G. A. Manente, L. Rossi, L. Mutti et al., Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells, Biochim Biophys Acta, vol.1832, pp.2085-2096, 2013.

J. Kovarova, M. Bajzikova, M. Vondrusova, J. Stursa, J. Goodwin et al., Mitochondrial targeting of alpha-tocopheryl succinate enhances its anti-mesothelioma efficacy, Redox Rep, vol.19, pp.16-25, 2014.

K. E. Hwang, Y. S. Kim, Y. R. Hwang, S. J. Kwon, D. S. Park et al., Pemetrexed induces apoptosis in malignant mesothelioma and lung cancer cells through activation of reactive oxygen species and inhibition of sirtuin 1, Oncol Rep, vol.33, pp.2411-2419, 2015.

J. M. Baughman, C. M. Rose, G. Kolumam, J. D. Webster, E. M. Wilkerson et al., Proteomics Reveals Bap1 Regulation of Metabolism. Cell Rep, vol.16, pp.583-595, 2016.

S. H. Chew and S. Toyokuni, Malignant mesothelioma as an oxidative stress-induced cancer: An update, Free Radic Biol Med, vol.86, pp.166-178, 2015.

E. Aldieri, C. Riganti, F. Silvagno, S. Orecchia, P. G. Betta et al., Antioxidants prevent the RhoA inhibition evoked by crocidolite asbestos in human mesothelial and mesothelioma cells, Am J Respir Cell Mol Biol, vol.45, pp.625-631, 2011.

A. Napolitano, L. Pellegrini, A. Dey, D. Larson, M. Tanji et al., Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma, Oncogene, vol.35, pp.1996-2002, 2016.

P. Poullet, S. Carpentier, and E. Barillot, myProMS, a web server for management and validation of mass spectrometry-based proteomic data, Proteomics, vol.7, pp.2553-2556, 2007.

Y. H. Yang, S. Dudoit, P. Luu, D. M. Lin, V. Peng et al., Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation, Nucleic Acids Res, vol.30, p.15, 2002.

M. Dai, P. Wang, A. D. Boyd, G. Kostov, B. Athey et al., Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data, Nucleic Acids Res, vol.33, p.175, 2005.